|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee S, Kang TW, Cha DI, Song KD, Lee MW,
Rhim H, Lim HK, Sinn DH, Kim JM and Kim K: Radiofrequency ablation
vs. surgery for perivascular hepatocellular carcinoma: Propensity
score analyses of long-term outcomes. J Hepatol. 69:70–78. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Romano A, Angeli P, Piovesan S, Noventa F,
Anastassopoulos G, Chemello L, Cavalletto L, Gambato M, Russo FP,
Burra P, et al: Newly diagnosed hepatocellular carcinoma in
patients with advanced hepatitis C treated with DAAs: A prospective
population study. J Hepatol. 69:345–352. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tokumitsu Y, Sakamoto K, Tokuhisa Y,
Matsui H, Matsukuma S, Maeda Y, Sakata K, Wada H, Eguchi H, Ogihara
H, et al: A new prognostic model for hepatocellular carcinoma
recurrence after curative hepatectomy. Oncol Lett. 15:4411–4422.
2018.PubMed/NCBI
|
|
5
|
Zhu Q, Li N, Zeng X, Han Q, Li F, Yang C,
Lv Y, Zhou Z and Liu Z: Hepatocellular carcinoma in a large medical
center of China over a 10-year period: Evolving therapeutic option
and improving survival. Oncotarget. 6:44402015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Parikh ND, Singal AG and Hutton DW: Cost
effectiveness of regorafenib as second-line therapy for patients
with advanced hepatocellular carcinoma. Cancer. 123:3725–3731.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang JD, Hainaut P, Gores GJ, Amadou A,
Plymoth A and Roberts LR: A global view of hepatocellular
carcinoma: Trends, risk, prevention and management. Nat Rev
Gastroenterol Hepatol. 22:589–604. 2019. View Article : Google Scholar
|
|
8
|
Zhu RX, Seto WK, Lai CL and Yuen MF:
Epidemiology of hepatocellular carcinoma in the Asia-Pacific
region. Gut Liver. 10:3322016. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Levrero M and Zucman-Rossi J: Mechanisms
of HBV-induced hepatocellular carcinoma. J Hepatol. 64 (Suppl
1):S84–S101. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sreedharan S, Shaik JH, Olszewski PK,
Levine AS, Schiöth HB and Fredriksson R: Glutamate, aspartate and
nucleotide transporters in the SLC17 family form four main
phylogenetic clusters: Evolution and tissue expression. BMC
Genomics. 11:172010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bissa B, Beedle AM and Govindarajan R:
Lysosomal solute carrier transporters gain momentum in research.
Clin Pharmacol Ther. 100:431–436. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Moriyama Y, Hiasa M, Sakamoto S, Omote H
and Nomura M: Vesicular nucleotide transporter (VNUT): Appearance
of an actress on the stage of purinergic signaling. Purinergic
Signal. 13:387–404. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao Q, Zhao K, Zhong XZ, Zou Y, Yu H,
Huang P, Xu TL and Dong XP: SLC17A9 protein functions as a
lysosomal ATP transporter and regulates cell viability. J Biol
Chem. 289:23189–23199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sillars-Hardebol AH, Carvalho B, Tijssen
M, Beliën JA, de Wit M, Delis-van Diemen PM, Pontén F, van de Wiel
MA, Fijneman RJ and Meijer GA: TPX2 and AURKA promote 20q
Amplicon-driven colorectal adenoma to carcinoma progression. Gut.
61:1568–1575. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Weinberg SE and Chandel NS: Targeting
mitochondria metabolism for cancer therapy. Nat Chem Biol.
11:92015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhai E, Liang W, Lin Y, Huang L, He X, Cai
S, Chen J, Zhang N, Li J, Zhang Q, et al: HSP70/HSP90-organizing
protein contributes to gastric Cancer progression in an autocrine
fashion and predicts poor survival in gastric Cancer. Cell Physiol
Biochem. 47:879–892. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cui H, Li L, Wang W, Shen J, Yue Z, Zheng
X, Zuo X, Liang B, Gao M, Fan X, et al: Exome sequencing identifies
SLC17A9 pathogenic gene in two Chinese pedigrees with disseminated
superficial actinic porokeratosis. J Med Genet. 51:699–704. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dereure O: Mutation in the SLC17A9 gene in
familial superficial actinic disseminated porokeratosis. Ann
Dermatol Venereol. 142:155–156. 2015.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Takai E, Tsukimoto M, Harada H, Sawada K,
Moriyama Y and Kojima S: Autocrine regulation of TGF-β1-induced
cell migration by exocytosis of ATP and activation of P2 receptors
in human lung cancer cells. J Cell Sci. 125:5051–5060. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang L, Chen Z, Xiong W, Ren H, Zhai E, Xu
K, Yang H, Zhang Z, Ding L, He Y, et al: High expression of SLC17A9
correlates with poor prognosis in colorectal cancer. Human Pathol.
84:62–70. 2019. View Article : Google Scholar
|
|
21
|
Li J, Su T, Yang L, Deng L, Zhang C and He
Y: High SLC17A9 expression correlates with poor survival in gastric
carcinoma. Future Oncol. 15:4155–4166. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Haanes KA, Kowal JM, Arpino G, Lange SC,
Moriyama Y, Pedersen PA and Novak I: Role of vesicular nucleotide
transporter VNUT (SLC17A9) in release of ATP from AR42J cells and
mouse pancreatic acinar cells. Purinergic Signal. 10:431–440. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Koike M, Nakanishi H, Saftig P, Ezaki J,
Isahara K, Ohsawa Y, Schulz-Schaeffer W, Watanabe T, Waguri S,
Kametaka S, et al: Cathepsin D deficiency induces lysosomal storage
with ceroid lipofuscin in mouse CNS neurons. J Neurosci.
20:6898–6906. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dou Y, Wu HJ, Li HQ, Qin S, Wang YE, Li J,
Lou HF, Chen Z, Li XM, Luo QM and Duan S: Microglial migration
mediated by ATP-induced ATP release from lysosomes. Cell Res.
22:1022–1033. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hong KO, Oh KY, Shin WJ, Yoon HJ, Lee JI
and Hong SD: Tumor budding is associated with poor prognosis of
oral squamous cell carcinoma and histologically represents an
epithelial-mesenchymal transition process. Hum Pathol. 80:123–129.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
De Smedt L, Palmans S, Andel D, Govaere O,
Boeckx B, Smeets D, Galle E, Wouters J, Barras D, Suffiotti M, et
al: Expression profiling of budding cells in colorectal cancer
reveals an EMT-like phenotype and molecular subtype switching. Br J
Cancer. 116:58–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen B, Jiang L, Zhong ML, Li JF, Li BS,
Peng LJ, Dai YT, Cui BW, Yan TQ, Zhang WN, et al: Identification of
fusion genes and characterization of transcriptome features in
T-cell acute lymphoblastic leukemia. Proc Natl Acad Sci USA.
115:373–378. 2018. View Article : Google Scholar : PubMed/NCBI
|
